AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement

MARKHAM, Ontario, September 30, 2009 – AlphaRx Inc., has entered into an exclusive collaboration and licensing agreement with Riso Pharma Tech for the development of ARX606T, an early stage product candidate intended for wound treatment.
Under the terms of the agreement, AlphaRx will give Riso exclusive global rights (with
the exception of Asia) of ARX606T, which makes [...]